Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
RESEARCH TOOLSreports
Establishment Labs Holdings (ESTA) Stock Price & Analysis
162 Followers
ESTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.96 - $73.00
Previous Close$50.8
Volume255.68K
Average Volume (3M)287.70K
Market Cap
$1.40B
Enterprise Value$1.52B
Total Cash (Recent Filing)$72.98M
Total Debt (Recent Filing)$195.37M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Aug 07, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.15
Shares Outstanding27,514,756
10 Day Avg. Volume170,144
30 Day Avg. Volume287,701
Standard Deviation0.17
R-Squared0.14
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)30.38
Price to Sales (P/S)44.29
Price to Cash Flow (P/CF)-32.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.76
Enterprise Value/Gross Profit14.21
Enterprise Value/Ebitda157.07
Forecast
1Y Price Target
$61.75Price Target Upside21.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Establishment Labs Holdings News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceESTA's initial sales guidance for the year outpaces market expectations, signaling strong revenue growth and confidence from management.
Market ExpansionThe anticipated launch of Motiva in China, coupled with the expanding presence in Asia and Europe, forecasts dynamic growth opportunities for ESTA.
Regulatory ApprovalManagement's expectation of a successful FDA review for Motiva implants hints at a new product launch, potentially boosting the company's market presence.
Bears Say
Financial CovenantsTranche D of the credit facility requires both Tranche C to be drawn and trailing twelve-month sales to exceed $195M.
Market DemandAcknowledging the recent slowdown in demand for breast procedures globally, management said distributor ordering patterns had an outsized impact on Q3 results.
Sales PerformanceAcknowledging the recent slowdown in demand for breast procedures globally, management again said distributor ordering patterns had an outsized impact on Q3 results while direct markets only experienced a single-digit decline.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ESTA FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was $16.96 and its highest was $73.00 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Currently, no data Available
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is Aug 07, 2024 which is in 63 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on May 08, 2024. The company reported -$0.58 earnings per share for the quarter, beating the consensus estimate of -$0.668 by $0.088.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -$0.51.
How many shares outstanding does Establishment Labs Holdings Inc have?
Establishment Labs Holdings Inc has 27,514,755 shares outstanding.
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -$0.58 in its last earnings report, beating expectations of -$0.668. Following the earnings report the stock price went up 10.888%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Among the largest hedge funds holding Establishment Labs Holdings Inc’s share is Perceptive Advisors LLC. It holds Establishment Labs Holdings Inc’s shares valued at 4M.
---
Establishment Labs Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$61.75 (21.56% Upside)
$61.75 (21.56% Upside)
Blogger Sentiment
Bullish
ESTA Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 331.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 7.1%
Last 30 Days ▼ 7.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.00%
12-Months-Change
Fundamentals
Return on Equity
-404.56%
Trailing 12-Months
Asset Growth
44.17%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
---
ESTA Earnings Call
Q1 2024
0:00 / 0:00
---
ESTA Stock 12 Month Forecast
Average Price Target
$61.75
▲(21.56% Upside)
Technical Analysis
Best Analysts Covering ESTA
1 Year
1 Year Success Rate
19/39 ratings generated profit
1 Year Average Return
+52.33%
reiterated a buy rating 28 days ago
Copying Marie Thibault's trades and holding each position for 1 Year would result in 48.72% of your transactions generating a profit, with an average return of +52.33% per trade.
---